0.02 | 0.34%
| Price and Volume | |
|---|---|
| Recent Price | 5.85 |
| 52 Week High | 6.20 |
| 52 Week Low | 5.17 |
| Avg. Daily Vol. (Mil) | 0.12 |
| Beta (3 year) | 0.85 |
| Share Related Items | |
| Mkt Cap (Mil) | 162.38 |
| Shares Out (Mil) | 27.76 |
| Float (Mil) | 26.12 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 65.00 |
| Current Ratio | 66.40 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 3.60 |
| Price/Sales | 286.38 |
| Price/Book | 1.04 |
| Price/Cash Flow | 3.50 |
| Per Share Data | |
| Earnings | 1.64 |
| Sales | 0.02 |
| Book Value | 5.63 |
| Cash Flow | 1.68 |
| Business Summary | |
|---|---|
| Maxygen, Inc. is a biotechnology company engaged in the discovery and development of improved next-generation protein pharmaceuticals for the treatment of disease and serious medical conditions. | |
| General Information | |
| 515 Galveston Drive
Redwood City, CA 94063 |
|
| www.maxygen.com | |
| Industry : Diversified Services | |
| Sector: Services | |
| Employees: 7 | |
| CEO: James R. Sulat | |
| Short Interest | |
| Current Month (Mil) | 0.95 |
| Previous Month (Mil) | 0.91 |
| Short Interest Ratio (Days) | 8.00 |
| Management Effectiveness | |
| Return on Equity | 29.80 |
| Return on Assets | 29.30 |
| Return on Investments | 29.80 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
106.76
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet